4:45 PM
 | 
Jan 11, 2019
 |  BC Extra  |  Company News

Atomwise, Charles River partnership brings CRO model to AI

Atomwise Inc. (San Francisco, Calif.) is scaling up delivery of its artificial intelligence-based medicinal chemistry technology through a partnership with Charles River Laboratories International Inc. (NYSE:CRL) announced Friday. The alliance gives drug developers a CRO access point for AI technologies, circumventing the need for individual deals, and provides Atomwise with additional streams of revenue and data to feed its platform.

Through the partnership, Charles...

Read the full 300 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >